The activation of M 1, muscarinic receptor signaling induces neuronal differentiation in pyramidal hippocampal neurons

Kathryn L. VanDeMark, Marina Guizzetti, Gennaro Giordano, Lucio G. Costa

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Muscarinic receptors have been proposed to play an important role during brain development by regulating cell survival, proliferation, and differentiation. This study investigated the effect of muscarinic receptor activation on prenatal rat hippocampal pyramidal neuron differentiation and the signal transduction pathways involved in this effect. The cholinergic agonist carbachol, after 24 h in vitro, increased the length of the axon, without affecting the length of minor neurites. Carbachol-induced axonal growth was also observed in pyramidal neurons from the neocortex but not in granule neurons from the cerebellum. The effect of carbachol was mediated by the M 1 subtype of muscarinic receptors. The Ca 2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester, the two protein kinase C (PKC) inhibitors 3-[1-[3-(dimethylaminopropyl]-1H- indol-3-yI]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) and 2-{8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyridol[1,2-a]indol-3-yl}-3- (1-methylindol-3-yl)maleim-ide (Ro-32-0432), and the extracellular signal-regulated kinase (ERK)1/2 inhibitors 2′-amino-3′- methoxyflavone (PD98O59) and 1,4-diamino-2,3-dicyano-1,4-bis(methylthio) butadiene (U0126) all blocked carbachol-induced axonal outgrowth. In addition, down-regulation of ERK1/2 with small interfering RNA abolished the neuritogenic effect of carbachol. These data suggest an involvement of Ca 2+, PKC, and ERK1/2 in carbachol-induced axonal growth. Carbachol indeed increased the release of Ca 2+ from intracellular stores and induced PKC and ERK1/2 activation. Additional experiments showed that PKC, but not Ca 2+, is involved in carbachol-induced ERK1/2 activation. Together, these results show that cholinergic stimulation of prenatal hippocampal pyramidal neurons accelerates axonal growth through the induction of Ca 2+ mobilization and the activation of PKC and especially of ERK1/2.

Original languageEnglish (US)
Pages (from-to)532-542
Number of pages11
JournalJournal of Pharmacology and Experimental Therapeutics
Volume329
Issue number2
DOIs
StatePublished - May 2009
Externally publishedYes

Fingerprint

Pyramidal Cells
Carbachol
Muscarinic Receptors
Protein Kinase C
Growth
Cholinergic Agonists
Pyrroles
Mitogen-Activated Protein Kinase 3
Protein C Inhibitor
Mitogen-Activated Protein Kinase 1
Neocortex
Neurites
Protein Kinase Inhibitors
Chelating Agents
Cerebellum
Cholinergic Agents
Small Interfering RNA
Axons
Cell Differentiation
Signal Transduction

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Medicine(all)

Cite this

The activation of M 1, muscarinic receptor signaling induces neuronal differentiation in pyramidal hippocampal neurons. / VanDeMark, Kathryn L.; Guizzetti, Marina; Giordano, Gennaro; Costa, Lucio G.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 329, No. 2, 05.2009, p. 532-542.

Research output: Contribution to journalArticle

@article{9bf716d5873c4d4782cd16b1887e6a9b,
title = "The activation of M 1, muscarinic receptor signaling induces neuronal differentiation in pyramidal hippocampal neurons",
abstract = "Muscarinic receptors have been proposed to play an important role during brain development by regulating cell survival, proliferation, and differentiation. This study investigated the effect of muscarinic receptor activation on prenatal rat hippocampal pyramidal neuron differentiation and the signal transduction pathways involved in this effect. The cholinergic agonist carbachol, after 24 h in vitro, increased the length of the axon, without affecting the length of minor neurites. Carbachol-induced axonal growth was also observed in pyramidal neurons from the neocortex but not in granule neurons from the cerebellum. The effect of carbachol was mediated by the M 1 subtype of muscarinic receptors. The Ca 2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester, the two protein kinase C (PKC) inhibitors 3-[1-[3-(dimethylaminopropyl]-1H- indol-3-yI]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) and 2-{8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyridol[1,2-a]indol-3-yl}-3- (1-methylindol-3-yl)maleim-ide (Ro-32-0432), and the extracellular signal-regulated kinase (ERK)1/2 inhibitors 2′-amino-3′- methoxyflavone (PD98O59) and 1,4-diamino-2,3-dicyano-1,4-bis(methylthio) butadiene (U0126) all blocked carbachol-induced axonal outgrowth. In addition, down-regulation of ERK1/2 with small interfering RNA abolished the neuritogenic effect of carbachol. These data suggest an involvement of Ca 2+, PKC, and ERK1/2 in carbachol-induced axonal growth. Carbachol indeed increased the release of Ca 2+ from intracellular stores and induced PKC and ERK1/2 activation. Additional experiments showed that PKC, but not Ca 2+, is involved in carbachol-induced ERK1/2 activation. Together, these results show that cholinergic stimulation of prenatal hippocampal pyramidal neurons accelerates axonal growth through the induction of Ca 2+ mobilization and the activation of PKC and especially of ERK1/2.",
author = "VanDeMark, {Kathryn L.} and Marina Guizzetti and Gennaro Giordano and Costa, {Lucio G.}",
year = "2009",
month = "5",
doi = "10.1124/jpet.108.150128",
language = "English (US)",
volume = "329",
pages = "532--542",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - The activation of M 1, muscarinic receptor signaling induces neuronal differentiation in pyramidal hippocampal neurons

AU - VanDeMark, Kathryn L.

AU - Guizzetti, Marina

AU - Giordano, Gennaro

AU - Costa, Lucio G.

PY - 2009/5

Y1 - 2009/5

N2 - Muscarinic receptors have been proposed to play an important role during brain development by regulating cell survival, proliferation, and differentiation. This study investigated the effect of muscarinic receptor activation on prenatal rat hippocampal pyramidal neuron differentiation and the signal transduction pathways involved in this effect. The cholinergic agonist carbachol, after 24 h in vitro, increased the length of the axon, without affecting the length of minor neurites. Carbachol-induced axonal growth was also observed in pyramidal neurons from the neocortex but not in granule neurons from the cerebellum. The effect of carbachol was mediated by the M 1 subtype of muscarinic receptors. The Ca 2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester, the two protein kinase C (PKC) inhibitors 3-[1-[3-(dimethylaminopropyl]-1H- indol-3-yI]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) and 2-{8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyridol[1,2-a]indol-3-yl}-3- (1-methylindol-3-yl)maleim-ide (Ro-32-0432), and the extracellular signal-regulated kinase (ERK)1/2 inhibitors 2′-amino-3′- methoxyflavone (PD98O59) and 1,4-diamino-2,3-dicyano-1,4-bis(methylthio) butadiene (U0126) all blocked carbachol-induced axonal outgrowth. In addition, down-regulation of ERK1/2 with small interfering RNA abolished the neuritogenic effect of carbachol. These data suggest an involvement of Ca 2+, PKC, and ERK1/2 in carbachol-induced axonal growth. Carbachol indeed increased the release of Ca 2+ from intracellular stores and induced PKC and ERK1/2 activation. Additional experiments showed that PKC, but not Ca 2+, is involved in carbachol-induced ERK1/2 activation. Together, these results show that cholinergic stimulation of prenatal hippocampal pyramidal neurons accelerates axonal growth through the induction of Ca 2+ mobilization and the activation of PKC and especially of ERK1/2.

AB - Muscarinic receptors have been proposed to play an important role during brain development by regulating cell survival, proliferation, and differentiation. This study investigated the effect of muscarinic receptor activation on prenatal rat hippocampal pyramidal neuron differentiation and the signal transduction pathways involved in this effect. The cholinergic agonist carbachol, after 24 h in vitro, increased the length of the axon, without affecting the length of minor neurites. Carbachol-induced axonal growth was also observed in pyramidal neurons from the neocortex but not in granule neurons from the cerebellum. The effect of carbachol was mediated by the M 1 subtype of muscarinic receptors. The Ca 2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester, the two protein kinase C (PKC) inhibitors 3-[1-[3-(dimethylaminopropyl]-1H- indol-3-yI]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) and 2-{8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyridol[1,2-a]indol-3-yl}-3- (1-methylindol-3-yl)maleim-ide (Ro-32-0432), and the extracellular signal-regulated kinase (ERK)1/2 inhibitors 2′-amino-3′- methoxyflavone (PD98O59) and 1,4-diamino-2,3-dicyano-1,4-bis(methylthio) butadiene (U0126) all blocked carbachol-induced axonal outgrowth. In addition, down-regulation of ERK1/2 with small interfering RNA abolished the neuritogenic effect of carbachol. These data suggest an involvement of Ca 2+, PKC, and ERK1/2 in carbachol-induced axonal growth. Carbachol indeed increased the release of Ca 2+ from intracellular stores and induced PKC and ERK1/2 activation. Additional experiments showed that PKC, but not Ca 2+, is involved in carbachol-induced ERK1/2 activation. Together, these results show that cholinergic stimulation of prenatal hippocampal pyramidal neurons accelerates axonal growth through the induction of Ca 2+ mobilization and the activation of PKC and especially of ERK1/2.

UR - http://www.scopus.com/inward/record.url?scp=65649091278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649091278&partnerID=8YFLogxK

U2 - 10.1124/jpet.108.150128

DO - 10.1124/jpet.108.150128

M3 - Article

VL - 329

SP - 532

EP - 542

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -